Biography

Dr Prentice is interested in novel radiotherapy techniques, radio-ligand therapy, the hormonal manipulation of prostate cancer and the management of older people with cancer.

He is the principal investigator for multiple clinical trials and has written international guidelines on prostate cancer management.

GMC number

6160554

• Prentice M. Mpima, S. Nasuti, P. & Payne, H. (2021)
Radical Prostate Radiotherapy and the Use of Androgen Deprivation in the Era of Risk Stratification; Does Real-World Practice Follow the Evidence?
Journal of Clinical Oncology 39(suppl) 216
• Scott, E. Pasciuti, K. Kubiak, M. Needleman, S. Marks. G, Smith, K & Prentice, M (2021)
Neutrophil-to-lymphocyte ratio (NLR) as a prognostic indicator of treatment response to novel hormones in metastatic castrate-resistant prostate cancer: Real-world data from a single institution. (2021)
Journal of Clinical Oncology 39(suppl) 52
• Scott, E. Kubiak, M. Needleman, S. Marks. G, Smith, K & Prentice, M (2020)
The Shift Towards Digital Appointments: the Response to COVID-19 Affecting Uro-Oncology
Clinical Oncology, On Line July 2020,
• Prentice, M. Mann, K. Payne, H.A. Wong, I –(2019)
Computer Modelling in Prostate Anti-Cancer Therapy
Journal of Clinical Oncology 37 Suppl (e16528) 2019
• Boyle, H.J., Alibhai, S., Decoster, L., Efstathiou, E., Fizazi, K., Mottet, N., Oudard, S., Payne, H., Prentice, M., Puts, M., Aapro, M., Droz, J.-P. – Review and International Guidelines (2019)
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older adults (2019)
European Journal of Cancer, July 2019, 116: 116-136
• Davda, R. Pendse, D. Mitra, M. Prentice, M et al (2019)
Separation and Rectal Dosimetry With A Hydrogel Spacer Inserted During Prostate HDR Brachytherapy
Radiotherapy and Oncology 133: S589-S590
• Shen, J. Prentice, M. et al (2019) - Review
Perspectives on Geriatric Oncology Research Presented at the 2019 American Society of Clinical Oncology Genitourinary Cancer Symposium (2019)
Journal of Geriatric Oncology 10(4) 523-525

 

Dr Prentice is the principal investigator for multiple clinical trials and has written international guidelines on prostate cancer management.